The report "Veterinary Diagnostics Market by product type (Hematology tests, Immunodiagnostics, Clinical Chemistry, Molecular Testing), by animal type (Canine, Feline, Bovine, Poultry (Poultry ELISA, Poultry PCR), Swine (Poultry ELISA, Poultry PCR) Others), by end user (Veterinary Hospitals, Veterinary Clinics, Research Laboratories)- Global Forecasts to 2030"
The report "Non Invasive Prenatal Testing Market by product type (Consumables and Reagents, Instruments), by end user (Public Labs, Private Labs) - Global Forecasts to 2030"
The global non-invasive prenatal testing market is projected to reach USD 3.6 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 9.6% during the forecast period 2024-2030. The growth of the market is majorly driven by the increasing number of babies with chromosomal disorders owing to the increasing number of late pregnancies
The report "Microbial Biopharmaceuticals Market by microbe type (Bacteria, Fungal & Yeast, Virus), by end product (Vaccines, Hormones, Antibody Derived Proteins, PEGylated Products, BL-2 Products), by application (Metabolic Disorders, Hormonal Disorders, Homological Disorders, Oncological Disorders) - Global Forecasts to 2030"
The report "Prostate Cancer Diagnostic Market By Test Type (Tumor Biomarker Tests, Imaging, Biopsy, Other) By Cancer Stage (Stage I, Stage II A, Stage II B, Stage III, Stage IV), By End User (Hospital Associated Labs, Independent Diagnostic Labs, Diagnostic Imaging Centers, Cancer Research Institutes, Others) - Global Forecasts to 2030"
The report "Metallic Stearates Market By Type (Zinc Stearates, Calcium Stearates, Magnesium Stearates, Aluminium Stearates, Lithium Stearates, Sodium Stearates, Others), By End-User (Polymer & Rubber, Pharmaceutical, Cosmetics, Building & Construction, Paints & Coatings, Others) - Global Forecasts to 2030"
The report "Cervical Cancer Treatment Market By Cancer Type (Squamous Cell Carcinomas, Adenocarcinomas, Adenosquamous Carcinomas, Others) By Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Others) By End User (Cancer Care Centers, Diagnostic Centers, Pharmacies, Others) - Global Forecasts to 2030"
The global indium gallium zinc oxide display market size was valued at USD 1,822.4 million in 2023 and is poised to grow at a significant CAGR of 10.4% during the forecast period 2024-30. It also includes market size and projection estimations for each of the five major regions from 2024 to 2030. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore, the study includes a global and regional estimation and is further split by nations and categories within each region.
The global energy efficient glass market size was valued at USD 32,585.0 million in 2023 and is poised to grow at a significant CAGR of 5.2% during the forecast period 2024-30. It also includes market size and projection estimations for each of the five major regions from 2024 to 2030. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore, the study includes a global and regional estimation and is further split by nations and categories within each region.
The global central nervous system therapeutics market size was valued at USD 133.8 billion in 2023 and is poised to grow at a significant CAGR of 7.4% during the forecast period 2024-30. It also includes market size and projection estimations for each of the five major regions from 2024 to 2030. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore, the study includes a global and regional estimation and is further split by nations and categories within each region.
The report "Pneumonia Therapeutics Market by therapeutics (Prevention Vaccines and Treatment Drugs), by distribution channel (Hospitals, Pharmaceutical Stores, and Others), by age group (Pediatric, Adult, and Geriatric) - Global Forecasts to 2030"
The global pneumonia therapeutics market is projected to reach USD 14,956.4 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period 2024-2030. The growth of the market is majorly driven by the rising number of ongoing clinical trials for vaccine development and drug molecules
